Skip to content

This "Legal" THC Is Popping Up in Merchant Portfolios

Growing consumer interest and shifting federal regulatory priorities on the cannabis industry have led to merchants capitalizing on certain market ambiguities. LegitScript has observed a growing trend of merchants offering products marketed as containing delta-8 THC, an isomer of the cannabis plant's most well-known and primary psychoactive compound, delta-9-tetrahydrocannabinol (delta-9 THC). Starting in 2020, LegitScript analysts have seen merchants attempting to circumvent scrutiny from payment service providers and regulatory agencies by marketing delta-8 THC products as a legal alternative to delta-9 THC, taking advantage of a perceived regulatory gray area surrounding delta-8 THC. 

 

Cannabis Compounds

There are a number of chemical compounds present in cannabis, referred to collectively as cannabinoids, with the most well-known cannabinoids being tetrahydrocannabinol (THC) and cannabidiol (CBD). At the federal level, one specific isomer of THC, delta-9 THC, is listed as a Schedule I controlled substance under the Controlled Substances Act (CSA). The passage of the Agriculture Improvement Act of 2018 (i.e., the 2018 Farm Bill) removed hemp - defined as cannabis, including any derivatives, extracts, cannabinoids, or isomers, containing less than 0.3% delta-9 THC on a dry weight basis - from the definition of "marihuana." Delta-8 THC is a tetrahydrocannabinol isomer, meaning it has the same chemical formula as delta-9 THC, but the atoms are arranged differently. Like delta-9 THC, delta-8 THC is known to be psychoactive.

 

The Legality Argument

Advocates of delta-8 THC argue that hemp-derived delta-8 THC became legal with the passage of the 2018 Farm Bill. Since this legislation did not explicitly mention delta-8 THC, merchants offering such products asserted that this compound, when derived from hemp and containing less than 0.3% delta-9 THC, is also legal. On August 21, 2020, the DEA issued an interim rule implementing the provisions of the 2018 Farm Bill which stated that "all synthetically derived tetrahydrocannabinols remain Schedule I controlled substances." This language is significant because delta-8 THC is only naturally found in trace amounts (i.e., less than 1%) in dried cannabis flower, regardless of whether the flower is marijuana or hemp. A product containing any substantial amount of delta-8 THC would almost certainly have to be produced synthetically through a relatively complicated extraction, isolation, conversion, and refinement process. In fact, it has been reported that some producers of delta-8 THC create it by mixing CBD with battery acid, pool chemicals, or even household vinegar. For this reason, many argue that because delta-8 THC products are synthetically derived tetrahydrocannabinols, they remain controlled in the United States under the CSA.

At the state level, at least 14 states currently ban delta-8 THC derived from hemp entirely, including Colorado, Arizona, and Alaska, which are states that currently allow recreational use of delta-9 THC products. State-level concerns largely center on preventing minors from accessing a psychotropic substance, the contents of which have likely not been verified by a lab. In fact, a recently published report has found that more than 50% of delta-8 THC products marketed as "hemp-derived" contained impermissible levels of delta-9 THC. State regulatory approaches have varied between states with some banning synthetic cannabinoids from hemp products, such as New York, naming delta-8 and delta-10 as examples, while other states like North Dakota have redefined THC in their state's controlled substance law to include any of its isomers "including delta-7, delta-8 and delta-10 THC." LegitScript believes this increase in state restrictions and the stated concerns related to minor access present significant risk of regulatory action in this area. 

 

Online Proliferation

Since LegitScript began tracking and reporting delta-8 THC in early 2020, we have uncovered hundreds of merchants in our clients' portfolios offering delta-8 THC products. Although the vast majority of the merchants offering delta-8 THC are based in the US, analysts have also observed merchant accounts based in the UK, Canada, and Australia. Typical delta-8 THC products closely resemble those offered by merchants selling other cannabis products, taking the form of cannabis flower, edibles such as food or dietary supplements, and as a distillate found in electronic vaporizer pens. 

Given delta-8 THC's recent growth in the online marketplace, LegitScript expects that demand for this substance will continue to increase.

 

Want to discover how LegitScript can help you reduce your risk around marijuana and CBD products? Contact us to learn more. 

Recent Blog Articles

AI and ROI in trust and safety.

Navigating Marketplace Risk: AI and the ROI of Trust and Safety

Every year, professionals from around the world come together at the Marketplace Risk Management Conference to discuss issues of risk on online platforms and other technology. Explore the most critical takeaways from 150+ industry-leading speakers spanning 70+ sessions. Then contact us to see how Le...
Pride Month Addiction Treatment Certification application fee waiver.

This Is How LegitScript Is Celebrating Pride Month

LegitScript is celebrating Pride Month by waiving application fees for a limited number of new applicants who provide specialty care for the LGBTQ+ community - along with addiction treatment services. Let's unfurl Pride Month's origins, and discuss why the LGBTQ+ community needs support for addictio...
Levels of risk.

What You Need to Know About the Different Levels of Merchant Risk

Many risk mitigation approaches focus on high-risk merchants, but what about medium-risk merchants? Being aware of the various levels of risk and which category your merchant falls into is a critical step in quantifying risk. Let's delve into what low-, medium-, and high-risk merchants are and the v...
Northern Colorado Hemp Exposition (NOCO)

Navigating Compliance: LegitScript’s Insights from NOCO

Join LegitScript on a journey to the 10th annual Northern Colorado Hemp Exposition (NOCO), where we immersed ourselves in the heart of the CBD industry. LegitScript shared critical compliance knowledge, exchanged insights with industry peers, and absorbed vital regulatory updates from the FDA and US...